Kesimpta (ofatumumab)

pCPA File Number: 21407
Negotiation Status:
Active Negotiation
Indication(s):
Relapsing-Remitting Multiple Sclerosis
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
SR0657-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable